SCHEMBL19475346

SCHEMBL19475346

Cn1ncc2ccc(OC(N)=O)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1C Q14123 1/20 0.47
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HAO1 Q9UJM8 1/20 0.43
PRMT5 O14744 4/20 0.43
ERCC1 P07992 1/20 0.42
ERCC4 Q92889 1/20 0.42
SCN9A Q15858 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
FASN P49327 1/20 0.41
HDAC4 P56524 2/20 0.40
NOTUM Q6P988 1/20 0.40
KMO O15229 1/20 0.40
WDR77 Q9BQA1 1/20 0.39
VNN1 O95497 1/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
EML4 Q9HC35 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707251 0.86 HAO1 (0.46) PDE1CHAO1PRMT5ERCC1ERCC4
SCHEMBL31729098 0.78 SMN1; SMN2 (0.62) MEN1KMT2AFASN
SCHEMBL15825245 0.78 KDM4E (0.55) MEN1KMT2APRMT5WDR77
SCHEMBL13113212 0.77 HTR2A (0.59) PDE1CMEN1KMT2AERCC1ERCC4
SCHEMBL29503149 0.76 AR (0.55) PDE1CKMT2AERCC1ERCC4FASN
SCHEMBL19691125 0.76 AR (0.55) PDE1CKMT2AERCC1ERCC4FASN
SCHEMBL26699112 0.75 CYP2A6 (0.46) MEN1KMT2A
SCHEMBL30444577 0.75 NOTUM (0.42) PDE1CHAO1PRMT5ERCC1ERCC4
SCHEMBL17473919 0.74 HTR2A (0.42) PDE1CHAO1PRMT5ERCC1ERCC4
SCHEMBL30006720 0.74 PDE1C (0.48) PDE1CERCC1ERCC4KMOVNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111479805-A Therapeutic indazoles 罗格斯新泽西州立大学 2020-07-31 CN disclosed
WO-2017184589-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-26 WO disclosed